The present invention provides an improved method for reducing the risk or severity of restenosis following cardiac angioplasty. The method includes administering to a target vessel region, a morpholino antisense compound having uncharged phosphorus-containing backbone linkages, and spanning the start codon of a human c-myc mRNA. Also disclosed are novel antisense compounds and compositions, and a method for assaying the effectiveness of antisense delivery and uptake to a target vessel region.

 
Web www.patentalert.com

< C3b/C4b Complement Receptor-like molecules and uses thereof

< Integrated chemical breather filter with high and low pressure surfaces

> Particle holding sheet, method of manufacturing particle holding sheet and organic electroluminescent display having particle holding sheet

> Porous or non-porous substrate coated with a polymeric composition having hydrophilic functional groups and process

~ 00284